NO743492L - Substituted cyclopentane derivative for use as an intermediate in the preparation of a physiologically active prostaglandin compound of the E or F series. - Google Patents

Substituted cyclopentane derivative for use as an intermediate in the preparation of a physiologically active prostaglandin compound of the E or F series.

Info

Publication number
NO743492L
NO743492L NO743492A NO743492A NO743492L NO 743492 L NO743492 L NO 743492L NO 743492 A NO743492 A NO 743492A NO 743492 A NO743492 A NO 743492A NO 743492 L NO743492 L NO 743492L
Authority
NO
Norway
Prior art keywords
series
preparation
physiologically active
prostaglandin compound
substituted cyclopentane
Prior art date
Application number
NO743492A
Other languages
Norwegian (no)
Other versions
NO144830C (en
NO144830B (en
Inventor
Hans Jürgen Ernst Hess
Jasjit Singh Bindra
Michael Ross Johnson
Thomas Ken Schaaf
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO743492L publication Critical patent/NO743492L/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO144830B publication Critical patent/NO144830B/en
Publication of NO144830C publication Critical patent/NO144830C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • C07F9/4059Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B63SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63BSHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B2211/00Applications
    • B63B2211/02Oceanography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO743492A 1972-07-13 1974-09-26 SUBSTITUTED CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE BY PREPARING A PHYSIOLOGY ACTIVE PROSTAGLAND CONNECTION OF THE E OR F SERIES NO144830C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27122072A 1972-07-13 1972-07-13

Publications (3)

Publication Number Publication Date
NO743492L true NO743492L (en) 1974-01-15
NO144830B NO144830B (en) 1981-08-10
NO144830C NO144830C (en) 1981-11-18

Family

ID=23034697

Family Applications (2)

Application Number Title Priority Date Filing Date
NO2724/73A NO143741C (en) 1972-07-13 1973-07-03 ANALOGY PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PROSTAGLAND CONNECTIONS OF THE E AND F SERIES
NO743492A NO144830C (en) 1972-07-13 1974-09-26 SUBSTITUTED CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE BY PREPARING A PHYSIOLOGY ACTIVE PROSTAGLAND CONNECTION OF THE E OR F SERIES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO2724/73A NO143741C (en) 1972-07-13 1973-07-03 ANALOGY PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PROSTAGLAND CONNECTIONS OF THE E AND F SERIES

Country Status (25)

Country Link
JP (4) JPS5241257B2 (en)
AR (2) AR209064A1 (en)
AT (1) AT367033B (en)
BE (1) BE802231A (en)
CA (1) CA1041495A (en)
CH (1) CH593254A5 (en)
CS (1) CS201027B2 (en)
DD (2) DD116459A5 (en)
DE (1) DE2334945A1 (en)
ES (4) ES416865A1 (en)
FI (1) FI57583C (en)
FR (1) FR2192834B1 (en)
GB (1) GB1446341A (en)
HU (4) HU171156B (en)
IE (1) IE37909B1 (en)
IL (2) IL42691A (en)
IN (1) IN138789B (en)
LU (1) LU68015A1 (en)
NL (1) NL7309792A (en)
NO (2) NO143741C (en)
PH (1) PH11461A (en)
SE (3) SE7705947L (en)
SU (4) SU644384A3 (en)
YU (1) YU187773A (en)
ZA (1) ZA734769B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
DE2416193C2 (en) 1974-04-03 1985-08-14 Hoechst Ag, 6230 Frankfurt Prostaglandin analogs, processes for their preparation and their use as cytoprotective agents
DE2463432C2 (en) * 1974-04-03 1987-06-19 Hoechst Ag, 6230 Frankfurt, De
ZA747723B (en) * 1974-12-11 1976-11-24 Pfizer 11-desoxy-15-substituted-omega-pentanor prostaglandins
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain
GB8329559D0 (en) * 1983-11-04 1983-12-07 Erba Farmitalia Furyl derivatives of 16-substituted prostaglandins preparations
SE9002596D0 (en) * 1990-08-08 1990-08-08 Pharmacia Ab A METHOD OF SYNTHESIS OF PROSTAGLANDIN DERIVATIVES
US6602900B2 (en) 1992-09-21 2003-08-05 Allergan, Inc. Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
KR100578616B1 (en) * 2004-07-23 2006-05-10 한미약품 주식회사 Method for the preparation of d-erythro-2,2-difluoro-2-deoxy-1-oxoribose
MX2016007717A (en) * 2013-12-13 2016-09-09 Allergan Inc Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
IL42373A (en) * 1972-06-02 1977-08-31 Pfizer Oxaprostagliandins and their preparation

Also Published As

Publication number Publication date
NO144830C (en) 1981-11-18
GB1446341A (en) 1976-08-18
HU171946B (en) 1978-04-28
AR214383A1 (en) 1979-06-15
LU68015A1 (en) 1974-01-21
AU5778473A (en) 1975-01-09
FR2192834B1 (en) 1979-04-06
CH593254A5 (en) 1977-11-30
SU645563A3 (en) 1979-01-30
PH11461A (en) 1978-02-01
ES437039A1 (en) 1977-01-01
HU171158B (en) 1977-11-28
ATA620773A (en) 1981-10-15
FI57583C (en) 1980-09-10
FR2192834A1 (en) 1974-02-15
IN138789B (en) 1976-04-03
JPS5241257B2 (en) 1977-10-17
HU172058B (en) 1978-05-28
ES437037A1 (en) 1977-01-01
IL50308A0 (en) 1976-10-31
SE7705945L (en) 1977-05-20
NO143741B (en) 1980-12-29
JPS5297958A (en) 1977-08-17
IL42691A0 (en) 1973-10-25
DE2334945A1 (en) 1974-03-07
BE802231A (en) 1974-01-14
ES437038A1 (en) 1977-01-01
JPS5293753A (en) 1977-08-06
JPS4992053A (en) 1974-09-03
SE7705946L (en) 1977-05-20
ZA734769B (en) 1974-06-26
SU645564A3 (en) 1979-01-30
JPS52122349A (en) 1977-10-14
DD109210A5 (en) 1974-10-20
DD116459A5 (en) 1975-11-20
NL7309792A (en) 1974-01-15
IL42691A (en) 1979-07-25
AT367033B (en) 1982-05-25
YU187773A (en) 1982-02-25
NO144830B (en) 1981-08-10
CA1041495A (en) 1978-10-31
HU171156B (en) 1977-11-28
CS201027B2 (en) 1980-10-31
SU584791A3 (en) 1977-12-15
FI57583B (en) 1980-05-30
IE37909B1 (en) 1977-11-09
NO143741C (en) 1981-04-08
AR209064A1 (en) 1977-03-31
SE7705947L (en) 1977-05-20
SU644384A3 (en) 1979-01-25
IE37909L (en) 1974-01-13
ES416865A1 (en) 1976-03-01

Similar Documents

Publication Publication Date Title
SE418080B (en) CFYCLOPROPANCARBOXYLIC ACID ESTERS FOR USE AS INSECTICIDE
SE400280B (en) 2-HALOGEN-4-SUBSTITUTED-6,7,8-TRIALCOXIKINAZOLINES FOR USE AS AN INTERMEDIATE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 2-SUBSTITUTED-4-AMINO-6,7,8-TRIALKOXIKINAZ
NO141752C (en) Substituted acetic acid esters for use as pesticides
SE422051B (en) ALKYNYLYCYLOPROPANCARBOXYLIC ACID ESTERS FOR USE AS INSECTICIDES
SE409707B (en) PROCEDURE FOR THE PREPARATION OF SULFOXIDES, WHICH ARE ANTONONISTS AGAINST CERTAIN EFFECTS OF HISTAMIN
SE435289B (en) O-SUBSTITUTED 7 BETA-AMINO-3-CEFEM-3-OL-4-CARBONIC ACID DERIVATIVES FOR USING AS INTERMEDIATE FOR THE PREPARATION OF O-SUBSTITUTED 7 BETA-ACYLAMINO-3-CEFEM-3-OL-4-OL-4-OL-4
SE411748B (en) CYCLEOPROPANCARBOXYLIC ACID ESTERS FOR USE AS PESTICIDES
SE417957B (en) OMEGA-SUBSTITUTED PROSTAGLANDIN ANALOGUES FOR USE AS ANTIFERTILITY AGENT
SE398879B (en) 1-AMINOURACILES FOR USE AS HERBICIDES
NO743492L (en) Substituted cyclopentane derivative for use as an intermediate in the preparation of a physiologically active prostaglandin compound of the E or F series.
NO149139C (en) DIMETHYLOX OXPHOSPHONATES FOR USE AS BASIC MATERIAL IN THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PROSTAGLANDINES
SE7601868L (en) CARBONITRILES FOR USE AS INTERMEDIATE PRODUCTS
SE395460B (en) PROCEDURE FOR THE PREPARATION OF 2BETA, 16BETA-DIPIPERIDINO-5ALFA-ANDROSTANES
SE416543B (en) SIBSTITUTED CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE IN THE PREPARATION OF PHARMACEUTICALLY ACTIVE PROSTAGLANDIN ANALOGS
SE411206B (en) N-PHENYLAMINES FOR USE AS HERBICIDES
NO146280C (en) BIS-TETRAHYDROPYRANYLETERS FOR USE AS INTERMEDIATE FOR PREPARING A PHYSIOLOGY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES
FI52735C (en) Process for the preparation of new pregnadiene-21-acid derivatives.
NO770869L (en) 5-CYCLOHEXYL-1-INDANOL FOR USE AS A STARTING MATERIAL IN THE PREPARATION OF 5-CYCLOHEXYLINE DECOMPOSITIONS.
AR205083A1 (en) PROCEDURE FOR THE PREPARATION OF SULFON SALTS OF 2-5-DIHYDROXY BENZENOSULPHONIC ACIDS
SE399259B (en) WAY TO REMOVE 2-AMINO-4-H-PYRANES, INTENDED FOR USE AS A DRUG
NO144069C (en) DIFLUORBUTYROPHENON DERIVATIVES USED FOR THE PREPARATION OF THERAPEUTIC ACTIVE BUTYROPHENON DERIVATIVES
NO740849L (en) Cyclopentanyl-tetrahydropyranyl-ether derivative for use in the preparation of physiologically active prostaglandins.
SE403915B (en) USE OF CHLORO-S-TRIAZINE DERIVATIVES AS ACTIVATIVES FOR A PEROXIDE INQUIRY
SE398113B (en) SUBSTITUTED DEODACADIANIC ACID ESTERS FOR USE AS INSECTICIDES
SE411350B (en) 15ALFA, 16ALFA-METHYLENE-4-PREGNENES FOR USE AS CONTRACTIVE AGENTS